source
- Garner Health secures $100 million funding, valuation climbs to $2.7 billionGarner Health announced a $100 million financing round that pushes its post‑money valuation to $2.7 billion. The capital raise was completed last month and was led by a group of venture investors.…
- Lilly proposes up to $1 billion for Alzheimer’s candidate, while Bial drops Parkinson’s programOn June 9, 2026, Eli Lilly announced a potential licensing agreement for an Alzheimer’s disease candidate, offering an upfront payment of $10 million and the possibility of more than $1 billion bas…